Pharmacist Motivational Interviewing: Mostly Positive Signals, Weakest in Randomized Trials

This systematic review of 45 studies maps where pharmacist-delivered motivational interviewing (MI) appears to help chronic disease management and adherence, and where randomized evidence tempers that optimism.

📅 Journal publication: Sep 17, 2026 · Last updated: Oct 23, 2026

motivational interviewingpharmacist-delivered MIstudent pharmacistsmedication adherencehypertensiondiabetessmoking cessationhyperlipidemiasystematic reviewambulatory carecommunity pharmacymanaged care Ambulatory Care / MTM

Background Information

Motivational interviewing by pharmacists boosts chronic disease management outcomes.

Motivational interviewing (MI) by pharmacists can impact chronic disease management by promoting behavior changes in patients. The review included 45 studies showing MI interventions led to positive or neutral outcomes, improving conditions like hypertension, lipidemia, and nicotine cessation. MI is a low-effort strategy for pharmacists to enhance patient outcomes, particularly for chronic disease management in ambulatory settings. Motivational interviewing by pharmacists can improve outcomes in chronic disease management.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Woodard B, LaPresta A, Eastes B, Tubb SM, Chen AMH

Citation: Woodard B, LaPresta A, Eastes B, et al. A Systematic Review of Pharmacists Using Motivational Interviewing and Patient Outcomes. Pharmacy (Basel, Switzerland). 2026;14(6). doi:10.3390/pharmacy14060136

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →